Edition:
United Kingdom

Crinetics Pharmaceuticals Inc (CRNX.OQ)

CRNX.OQ on NASDAQ Stock Exchange Global Select Market

33.58USD
14 Dec 2018
Change (% chg)

$-0.23 (-0.68%)
Prev Close
$33.81
Open
$34.20
Day's High
$34.20
Day's Low
$33.06
Volume
16,036
Avg. Vol
23,267
52-wk High
$40.78
52-wk Low
$19.25

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Wendall Wierenga

70 Chairman of the Board

R. Scott Struthers

Chief Executive Officer, Co-Founder, Director

Stephen Betz

Co-Founder, Vice President - Biology

Yun-Fei Zhu

Co-Founder, Vice President - Chemistry

Marc Wilson

Chief Financial Officer